全文获取类型
收费全文 | 4635篇 |
免费 | 240篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 303篇 |
妇产科学 | 135篇 |
基础医学 | 572篇 |
口腔科学 | 105篇 |
临床医学 | 333篇 |
内科学 | 1131篇 |
皮肤病学 | 97篇 |
神经病学 | 165篇 |
特种医学 | 102篇 |
外科学 | 696篇 |
综合类 | 188篇 |
一般理论 | 1篇 |
预防医学 | 217篇 |
眼科学 | 193篇 |
药学 | 296篇 |
1篇 | |
中国医学 | 16篇 |
肿瘤学 | 274篇 |
出版年
2023年 | 31篇 |
2022年 | 74篇 |
2021年 | 176篇 |
2020年 | 81篇 |
2019年 | 128篇 |
2018年 | 159篇 |
2017年 | 109篇 |
2016年 | 124篇 |
2015年 | 141篇 |
2014年 | 180篇 |
2013年 | 221篇 |
2012年 | 350篇 |
2011年 | 349篇 |
2010年 | 194篇 |
2009年 | 154篇 |
2008年 | 251篇 |
2007年 | 265篇 |
2006年 | 197篇 |
2005年 | 177篇 |
2004年 | 172篇 |
2003年 | 152篇 |
2002年 | 138篇 |
2001年 | 92篇 |
2000年 | 99篇 |
1999年 | 82篇 |
1998年 | 37篇 |
1997年 | 21篇 |
1996年 | 13篇 |
1994年 | 21篇 |
1993年 | 14篇 |
1992年 | 61篇 |
1991年 | 66篇 |
1990年 | 52篇 |
1989年 | 64篇 |
1988年 | 36篇 |
1987年 | 41篇 |
1986年 | 33篇 |
1985年 | 36篇 |
1984年 | 16篇 |
1983年 | 24篇 |
1982年 | 21篇 |
1980年 | 12篇 |
1979年 | 25篇 |
1977年 | 12篇 |
1976年 | 22篇 |
1974年 | 11篇 |
1973年 | 16篇 |
1969年 | 13篇 |
1968年 | 13篇 |
1966年 | 14篇 |
排序方式: 共有4884条查询结果,搜索用时 15 毫秒
1.
2.
3.
Usha Patel Manish Pandey Sadhana Kannan Tanuja A. Samant Poonam Gera Neha Mittal Swapnil Rane Asawari Patil Vanita Noronha Amit Joshi Vijay M. Patil Kumar Prabhash Manoj B. Mahimkar 《British journal of cancer》2020,123(12):1757
Background Anti-EGFR-based therapies have limited success in HNSCC patients. Predictive biomarkers are greatly needed to identify the patients likely to be benefited from these targeted therapies. Here, we present the prognostic and predictive association of biomarkers in HPV-negative locally advanced (LA) HNSCC patients.Methods Treatment-naive tumour tissue samples of 404 patients, a subset of randomised Phase 3 trial comparing cisplatin radiation (CRT) versus nimotuzumab plus cisplatin radiation (NCRT) were analysed to evaluate the expression of HIF1α, EGFR and pEGFR by immunohistochemistry and EGFR gene copy change by FISH. Progression-free survival (PFS), locoregional control (LRC) and overall survival (OS) were estimated by Kaplan–Meier method. Hazard ratios were estimated by Cox proportional hazard models.Results Baseline characteristics of the patients were balanced between two treatment groups (CRT vs NCRT) and were representative of the trial cohort. The median follow-up was of 39.13 months. Low HIF1α was associated with better PFS [HR (95% CI) = 0.62 (0.42–0.93)], LRC [HR (95% CI) = 0.56 (0.37–0.86)] and OS [HR (95% CI) = 0.63 (0.43–0.93)] in the CRT group. Multivariable analysis revealed HIF1α as an independent negative prognostic biomarker. For patients with high HIF1α, NCRT significantly improved the outcomes [PFS:HR (95% CI) = 0.55 (0.37–0.82), LRC:HR (95% CI) = 0.55 (0.36–0.85) and OS:HR (95% CI) = 0.54 (0.36–0.81)] compared to CRT. While in patients with low HIF1α, no difference in the clinical outcomes was observed between treatments. Interaction test suggested a predictive value of HIF1α for OS (P = 0.008).Conclusions High HIF1α expression is a predictor of poor clinical response to CRT in HPV-negative LA-HNSCC patients. These patients with high HIF1α significantly benefited with the addition of nimotuzumab to CRT.Clinical trial registration Registered with the Clinical Trial Registry of India (Trial registration identifier—CTRI/2014/09/004980).Subject terms: Tumour biomarkers, Head and neck cancer, Tumour biomarkers, Head and neck cancer, Predictive markers 相似文献
4.
5.
6.
Sameer Arora Kamal Shemisa Muthiah Vaduganathan Arman Qamar Ankur Gupta Sushil K. Garg Dharam J. Kumbhani Helen Mayo Houman Khalili Ambarish Pandey Sandeep R. Das 《Journal of the American College of Cardiology》2019,73(19):2454-2464
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor. 相似文献
7.
A. Al Tahan S. Arora A. Alzeer F. Al Tahan T. Malabarey A. Daif 《European journal of neurology》1997,4(1):52-58
The diagnosis of acute disseminated encephalomyelitis (ADEM) is frequently missed or delayed with consequent delay in instituting therapy in the crucial phase of the illness. The role of MRI in the diagnosis of ADEM is well established, however, the value of its early utilization of treatment on the outcome of patients has not been adequately stressed. Three patients with ADEM are described. Delay in the diagnosis of the first was associated with severe sequelae, while in the other two early diagnosis and institution of corticosteroid therapy which was facilitated by MRI, was associated with a better outcome. MRI should be carried out early once the diagosis of ADEM is entertained. 相似文献
8.
9.
10.
Anti-inflammatory activity and protective effect against CCl (4)-induced hepatotoxicity of alcoholic extract of leaves of WITHANIA SOMNIFERA have been assessed. The leaves were found to possess marked effects in subacute inflammation and hepatotoxicity. A comparison of the anti-inflammatory properties revealed the extract at 1 g/kg dose to be as active as 50 mg/kg of phenylbutazone and 10 mg/kg of hydrocortisone. The protective effect of the extract at 1 g/kg dose against CCl (4)-induced hepatotoxicity was comparable to 10 mg/kg of hydrocortisone. 相似文献